Trials / Completed
CompletedNCT02624271
Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk
Non Invasive Diagnosis of Gastric Precancerous Lesions by GastroPanel Blood Test in Patients With Increased Gastric Cancer Risk : a French Multicenter Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,000 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite the declining incidence, gastric cancer (GC) remains the second leading cause of cancer death worldwide. In France, it is the second digestive cancer with 7,000 new cases per year. It is now well demonstrated that patients with H. pylori infection, atrophic gastritis and intestinal metaplasia, have a high risk of developing GC. It is therefore important to detect these pre-neoplastic lesions at an early stage to improve patients prognosis. Thus, the aim of this project is to investigate the possible screening of gastric precancerous lesions by a blood test (GastroPanel®) in France, in patients with oesophagogastroduodenoscopy (EGD) prescription.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood samples analysis | Analyze blood samples with GastroPanel test to detect gastric precancerous lesions. |
Timeline
- Start date
- 2016-08-04
- Primary completion
- 2019-05-09
- Completion
- 2019-05-09
- First posted
- 2015-12-08
- Last updated
- 2023-11-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02624271. Inclusion in this directory is not an endorsement.